• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

代谢功能障碍相关脂肪性肝病与恶性肿瘤：揭开沉默破坏者的面纱

Metabolic dysfunction-associated steatotic liver disease and malignancies: Unmasking a silent saboteur.

作者信息

Polyzos Stergios A, Mantzoros Christos S

机构信息

First Laboratory of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Internal Medicine, Boston VA Healthcare System, Harvard Medical School, Boston, MA, USA.

出版信息

Metabolism. 2025 Jul;168:156253. doi: 10.1016/j.metabol.2025.156253. Epub 2025 Mar 29.

DOI:10.1016/j.metabol.2025.156253
PMID:40164408
Abstract

Not required for Editorials.

摘要

社论不需要。

相似文献

1
Metabolic dysfunction-associated steatotic liver disease and malignancies: Unmasking a silent saboteur.代谢功能障碍相关脂肪性肝病与恶性肿瘤：揭开沉默破坏者的面纱
Metabolism. 2025 Jul;168:156253. doi: 10.1016/j.metabol.2025.156253. Epub 2025 Mar 29.
2
What is new in metabolic dysfunction-associated steatotic liver disease?代谢功能障碍相关脂肪性肝病有哪些新进展？
J Diabetes Investig. 2025 Apr;16(4):581-583. doi: 10.1111/jdi.70003. Epub 2025 Feb 1.
3
Mechanism of PANoptosis in metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病中 PANoptosis 的机制。
Clin Res Hepatol Gastroenterol. 2024 Aug;48(7):102381. doi: 10.1016/j.clinre.2024.102381. Epub 2024 May 29.
4
Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management.代谢功能障碍相关脂肪性肝病：诊断与管理的近期转折点
Metabolism. 2024 Aug;157:155936. doi: 10.1016/j.metabol.2024.155936. Epub 2024 May 17.
5
The therapeutic potential of different mesenchymal stem cells and their derived exosomes in metabolic dysfunction-associated steatotic liver disease.不同间充质干细胞及其衍生外泌体在代谢功能障碍相关脂肪性肝病中的治疗潜力。
Front Endocrinol (Lausanne). 2025 Apr 3;16:1558194. doi: 10.3389/fendo.2025.1558194. eCollection 2025.
6
Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis.循环血管生成素样蛋白8（ANGPTL8）与代谢功能障碍相关的脂肪性肝病：最新系统评价与荟萃分析
Front Endocrinol (Lausanne). 2025 Apr 10;16:1574842. doi: 10.3389/fendo.2025.1574842. eCollection 2025.
7
Metabolic dysfunction-associated steatotic liver disease and its link to cancer.代谢功能障碍相关脂肪性肝病及其与癌症的联系。
Metabolism. 2024 Nov;160:156004. doi: 10.1016/j.metabol.2024.156004. Epub 2024 Aug 23.
8
High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort.非酒精性脂肪性肝病与代谢相关脂肪性肝病在 TARGET-NASH 真实世界队列中具有高度一致性。
Am J Gastroenterol. 2024 Aug 1;119(8):1624-1627. doi: 10.14309/ajg.0000000000002796. Epub 2024 Apr 8.
9
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis.代谢功能障碍相关脂肪性肝炎的当前治疗现状
Int J Mol Sci. 2025 Feb 19;26(4):1778. doi: 10.3390/ijms26041778.
10
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease.代谢相关脂肪性肝病：新命名对美国肝病研究学会非酒精性脂肪性肝病实践指南的影响及更新。
Hepatology. 2024 May 1;79(5):1212-1219. doi: 10.1097/HEP.0000000000000670. Epub 2023 Nov 9.